Charity aims to encourage the prioritization of sight loss in NHS

Article

More attention should be paid to dealing with sight loss, claims a new report created by ocular charity Visionary.

More attention should be paid to dealing with sight loss, claims a new report created by ocular charity Visionary.

The research is based on an evaluation of 68 Primary Care Trusts (PCTs) completed by the charity. The results revealed a significant difference in the level and quality of treatment administered across the UK.

Visionary is encouraging the NHS Commissioning Board to take action to ensure eye care is equally prioritized nationwide. The NHS initiative Action on Cataract aimed to perform 3200 cataract procedures per 100000 in patients over 65 years of age. However, the latest findings show that 11 PCTs in the UK are not reaching this target.

Angela Tinker, Chief Executive of Visionary, commented, "It is frightening that in the modern health service the reality is you could lose your sight despite there being effective treatments available. People should not be made to live with the devastating effects of sight loss or impairment simply because of where they live."

"At a local level we want to make sure systems are in place in the new NHS to help people get the right treatment fast. At the national level we want to ensure that the power is in place to redress the imbalance in the current postcode lottery to avoid unnecessary sight impairment and sight loss which seems inevitable in the current conditions."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.